Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial-Reference-Cited by-同舟云学术

Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial

Published:2019-12-14 Issue:46 Volume:25 Page:6790-6798
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Kim So Jeong,Chung Jun-Won,Woo Hyun Sun,Kim Su Young,Kim Jung Ho,Kim Yoon Jae,Kim Kyoung Oh,Kwon Kwang An,Park Dong Kyun

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference31 articles.

1. Pathogenesis and clinical management of Helicobacter pylori gastric infection

2. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

3. Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?

4. Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018

5. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection;American Journal of Gastroenterology;2024-09

2. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of <i>Helicobacter pylori</i> in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials;Biological and Pharmaceutical Bulletin;2024-08-01

3. The preventative effects of Lactococcus Lactis metabolites against LPS-induced sepsis;Frontiers in Microbiology;2024-07-17

4. Novel therapeutic regimens against Helicobacter pylori: an updated systematic review;Frontiers in Microbiology;2024-06-07

5. Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial);Scientific Reports;2024-04-18